2022. Biomarker Qualification Pathways: A Perspective on Why Promising Markers Stall Before Regulatory Acceptance. Translational Medicine & Therapeutics Journal. 1, 1 (May 2022), 46–55. DOI:https://doi.org/10.5281/zenodo.22648855.